Observational studyEuropean journal of clinical pharmacology2025
Comparison of kinetic and standard formulas for estimating glomerular filtration rate in acute kidney injury: implications for antibiotic dosing, a prospective study.
Observational study in European journal of clinical pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAcute kidney injury (AKI) is a prevalent complication in critically care, affecting prognosis and management. Standard formulas for estimating glomerular filtration rate (GFR), such as CKD-EPI and MDRD, are frequently used; accuracy in AKI is limited due to fluctuating creatinine. This study aimed to evaluate the agreement between standard GFR and kinetic-GFR formulas in AKI patients and to assess the impact on antibiotic dosing.
methodsIn this prospective, observational study conducted at Erciyes University Hospital, 100 patients with AKI were enrolled. GFR was estimated using CKD-EPI, MDRD, and kinetic-GFR formulas, including volume-adjusted kinetic formulas. Agreement between formulas was analyzed using Kappa coefficient.
resultsStatistically significant but imperfect agreement was observed between kinetic and standard formulas (CKD-EPI: κ = 0.592 ± 0.026, p < 0.001; MDRD: κ = 0.649 ± 0.025, p < 0.001). Approximately 28-30% of follow-up days revealed category mismatches between standard and kinetic formulas. 47% of the mismatches of CKD-EPI vs ki-CKD-EPI, and 31% for MDRD vs ki-MDRD occurred on day 2. Volume-adjusted kinetic formulas increased the mismatch rate, with CKD-EPI increasing from 28.5% to 30.6% (p < 0.001) and MDRD from 24.4% to 27.2% (p < 0.001). Significant dose adjustments were required when kinetic-GFR was used, particularly for nephrotoxic antibiotics.
conclusionThe use of kinetic-GFR formulas improves the accuracy of GFR estimation in AKI, especially in the early stages, and may lead to more appropriate antibiotic dosing. However, further studies are needed to fully understand the clinical implications, especially regarding drug levels and patient outcomes.
Indexed as
Identifiers
40824303What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.